Journal of Clinical Medicine (Dec 2022)

Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 Infection

  • Leszek Gromadziński,
  • Maciej Żechowicz,
  • Beata Moczulska,
  • Michał Kasprzak,
  • Klaudyna Grzelakowska,
  • Paulina Nowek,
  • Dominika Stępniak,
  • Natalia Jaje-Rykowska,
  • Aleksandra Kłosińska,
  • Mikołaj Pożarowszczyk,
  • Aleksandra Wochna,
  • Adam Kern,
  • Jerzy Romaszko,
  • Agata Sobacka,
  • Przemysław Podhajski,
  • Aldona Kubica,
  • Jacek Kryś,
  • Maciej Piasecki,
  • Piotr Lackowski,
  • Małgorzata Jasiewicz,
  • Eliano Pio Navarese,
  • Jacek Kubica

DOI
https://doi.org/10.3390/jcm12010143
Journal volume & issue
Vol. 12, no. 1
p. 143

Abstract

Read online

Background: The identification of parameters that would serve as predictors of prognosis in COVID-19 patients is very important. In this study, we assessed independent factors of in-hospital mortality of COVID-19 patients during the second wave of the pandemic. Material and methods: The study group consisted of patients admitted to two hospitals and diagnosed with COVID-19 between October 2020 and May 2021. Clinical and demographic features, the presence of comorbidities, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parameters with in-hospital mortality was evaluated. Results: A total of 1040 COVID-19 patients (553 men and 487 women) qualified for the study. The in-hospital mortality rate was 26% across all patients. In multiple logistic regression analysis, age ≥ 70 years with OR = 7.8 (95% CI 3.17–19.32), p p = 0.004, the presence of typical COVID-19-related lung abnormalities visualized in chest computed tomography ≥40% with OR = 2.5 (95% CI 1.05–6.23), p = 0.037, and a concomitant diagnosis of coronary artery disease with OR = 3.5 (95% CI 1.38–9.10), p = 0.009 were evaluated as independent risk factors for in-hospital mortality. Conclusion: The relationship between clinical and laboratory markers, as well as the advancement of lung involvement by typical COVID-19-related abnormalities in computed tomography of the chest, and mortality is very important for the prognosis of these patients and the determination of treatment strategies during the COVID-19 pandemic.

Keywords